$0.870
-0.029 (-3.33%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
RDHL 相似圖表分析預測
Alphio's RDHL stock price prediction model matches the current Redhill Biopharma Ltd tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $0.87 (+0.49%). The 1-week path is $0.88 (+1.52%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 Redhill Biopharma Ltd 股票嗎？
Redhill Biopharma Ltd (RDHL) is currently not a strong buy due to its high RSI of 72.825, indicating overbought conditions, and a forward P/E ratio of 1428.57, which suggests that the stock is highly overvalued compared to its earnings potential. While there is potential for growth due to the recent FDA designations, the company has a significant risk with a current ratio of 0.54, indicating potential liquidity issues.
RDHL 股價於 Tuesday 收在 $0.87，此前下跌 -3.33%
Redhill Biopharma Ltd (RDHL) last closed at $0.87, losing -3.33%. These facts feed the 1-day and 1-week RDHL price prediction above.
分析師一致預期
Redhill Biopharma Ltd（RDHL）：買進 4、持有 0、賣出 0。展望：Strong Buy。
Sell / Buy
Technical signals summary based on buy and sell indicators. The gauge shows the overall market view.
預測驅動因素
Redhill Biopharma Ltd（RDHL）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bearish
SMA 20
Bullish
SMA 200
Bearish
相似圖表形態
近期走勢與 RDHL 最接近的股票，依相似度排序。
RDHL 季節性分析
Historically the probability of a positive September return for RDHL is 0.00%. January offers the highest probability of a positive month at 44.26%, while March is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。